The Anticoagulant Reversal Drugs market size is expected to reach $2.65 billion in 2030 at a CAGR of 9.8%, driven by increased DOAC usage and demand for rapid emergency reversal therapies.
Read More
The Anticholinergic Drugs market size is expected to reach $8.87 billion in 2030 at a CAGR of 7.0%, driven by formulation innovation and rising overactive bladder treatment demand.
Read More
The Anti-CD20 Monoclonal Antibodies market size is expected to reach $12.94 billion in 2030 at a CAGR of 7.5%, driven by biosimilar development and expanded autoimmune disease treatment use.
Read More
The Anti-Cancer MAbs market size is expected to reach $112.41 billion in 2030 at a CAGR of 9.5%, driven by personalized oncology care and advances in antibody engineering.
Read More
The Antibody Fragments market size is expected to reach $17.56 billion in 2030 at a CAGR of 9.3%, driven by growth in targeted cancer therapies and precision biologics development.
Read More
The Antibody Drug Conjugates Contract Manufacturing market size is expected to reach $16.5 billion in 2030 at a CAGR of 9.6%, driven by oncology pipeline expansion.
Read More
The Antibody Drug Conjugates market size is expected to reach $46.95 billion in 2030 at a CAGR of 23.3%, driven by personalized oncology treatments and targeted drug delivery advances.
Read More
The Antibody Discovery market size is expected to reach $15.79 billion in 2030 at a CAGR of 10.1%, driven by personalized medicine demand and AI-enabled drug discovery platforms.
Read More
The Antibiotics market size is expected to reach $115.82 billion in 2030 at a CAGR of 5.5%, driven by rising antibiotic resistance and expanding personalized healthcare adoption.
Read More
The Antibacterial Silver Spray market size is expected to reach $2.63 billion in 2030 at a CAGR of 13.0%, driven by demand for advanced antimicrobial formulations and nano-silver innovations.
Read More